Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumorsSamuel Cheshier, Siddhartha S. Mitra, Abdullah H. Feroze et al.|Science Translational Medicine|2017Cited by 427
Myxoid glioneuronal tumor, <i>PDGFRA</i> p.K385‐mutant: clinical, radiologic, and histopathologic featuresCalixto‐Hope G. Lucas, David A. Solomon, Nancy Ann Oberheim Bush et al.|Brain Pathology|2019Cited by 75